136 results on '"Kim, S. J."'
Search Results
2. PULMONARY ASPERGILLOSIS AFTER SOLID ORGAN TRANSPLANTATION: DIAGNOSIS AND TREATMENT BASED ON SINGLE CENTER EXPERIENCES FOR 28 YEARS
3. THE CLINICAL SIGNIFICANCE OF THE HYPOXIA INDUCIBLE FACTOR-1A AND C4D IN IMPLANTATION RENAL BIOPSIES AND POST-TRANSPLANT BIOPSIES.
4. LIVER TRANSPLANTATION IN A PEDIATRIC PATIENT WITH BILIARY ATRESIA AND POLYSPLENIA SYNDROME: A CASE REPORT
5. ADVERSE EFFECTS OF HYPERURICEMIA ON RENAL TRANSPLANT OUTCOME IN SEVERITY-DEPENDENT MANNER
6. EXCHANGE LIVING-DONOR KIDNEY TRANSPLANTATION; ITS MERIT AND LIMITATION
7. CHRONOLOGICALLY DIFFERENT INCIDENCE OF POST-TRANSPLANT MALIGNANCY IN RENAL TRANSPLANT RECIPIENTS; 25 YEARS EXPERIENCE IN KOREAN SINGLE CENTER
8. RISK FACTORS OF ACUTE CELLULAR REJECTION IN ADULT LIVING DONOR LIVER TRANSPLANTATION: POSITIVE LYMPHOCYTOTOXIC CROSS-MATCH IS NOT A RISK FACTOR
9. LIVING DONOR LIVER TRANSPLANTATION USING A GRAFT FROM SITUS INVERSUS DONOR
10. BENEFICIAL EFFECTS ON THE RENAL FUNCTION OF BOTH THE RECIPIENTS AND DONORS IN LIVING DONOR KIDNEY TRANSPLANTATION
11. POTENTIAL REGULATORY EFFECT OF NICOTINAMIDE ON EARLY ISLET FAILURE FOLLOWING INTRAPORTAL TRANSPLANTATION
12. IMPACT OF CYTOKINE GENE POLYMORPHISM ON RENAL ALLOGRAFT OUTCOME COULD BE MODULATED BY IMMUNOSUPPRESSANT?
13. THE UCSF CRITERIA ACCORDING TO THE PRE-TRANSPLANT RADIOLOGIC STUDY CAN NOT ASSURE SIMILAR POST-TRANSPLANT RESULTS OF HEPATOCELLULAR CARCINOMA PATIENT WITHIN MILAN CRITERIA
14. EFFECT OF HEPARIN ON EARLY ISLET FAILURE AFTER INTRAPORTAL TRANSPLANTATION IN SYNGENEIC AND ALLOGENEIC MODEL
15. DONOR COMPLICATION AND SATISFACTION ASSESSMENT AFTER LIVING DONOR LIVER TRANSPLANTATION USING RIGHT LOBE GRAFT
16. PREDISPOSING FACTOR OF ACUTE RENAL FAILURE REQUIRING CONTINUOUS RENAL REPLACEMENT THERAPY AFTER LIVER TRANSPLANTATION
17. EFFECT OF PRE-TRANSPLANT LEVEL AND POST- TRANSPLANT SERIAL CHANGE OF SOLUBLE CD30 ON THE INCIDENCE OF BIOPSY-PROVEN ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION
18. ASSOCIATION OF MDR-1 AND CYP3A5 POLYMORPHISM WITH TACROLIMUS DISPOSITION IN KOREAN RENAL TRANSPLANTATION RECIPIENTS
19. PROLONGED COLD ISCHEMIC TIME IS A RISK FACTOR FOR BILIARY STRICTURES IN DUCT-TO-DUCT BILIARY RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION.
20. IN VITRO FUNCTIONAL ASSESSMENT OF BAL USING IMMOBILIZED PIG HEPATOCYTES IN PLASMA
21. BASILIXIMAB WITH DELAYED TACROLIMUS INDUCTION THERAPY IN LIVER TRANSPLANTATION
22. INHIBITORY EFFECTS OF ANTI-CD45RB MONOCLONAL ANTIBODIES ON T CELLS IN ALLOGENEIC SKIN TRANSPLANTATION
23. GENOTYPIC RESISTANCE OF HEPATITIS B VIRUS TO LAMIVUDINE IN RENAL RECIPIENTS
24. BLOCKING OF 4-1BBL PROMOTES LONG-TERM SURVIVAL IN SKIN ALLOGRAFT TREATED WITH ANTI-CD45RB AND ANTI-CD40L MONOCLONAL ANTIBODIES.
25. CAN HIGH HILAR DISSECTION REDUCE BILIARY COMPLICATION IN LIVING DONOR LIVER TRANSPLANTATION?
26. SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION IN TYPE II DIABETES
27. ISLET AUTOTRANSPLANTATION AFTER PANCREATECTOMY
28. BLOCKING OF IL-2 PATHWAY IN COSTIMULATION BLOCKADE INDUCED BONE MARROW CHIMERISM AFFECTS ADVERSELY ON MURINE SKIN GRAFT SURVIVAL
29. CLINICAL SIGNIFICANCE OF HUMAN PARVOVIRUS B19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS
30. MICROVASCULAR TUMOR EMBOLISM; INDEPENDENT PROGNOSTIC FACTOR AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
31. HEPATITIS B VIRUS INFECTION FROM HEPATITIS B SURFACE ANTIGEN-NEGATIVE, HEPATITIS B CORE ANTIBODY-POSITIVE DONORS IN LIVING-RELATED LIVER TRANSPLANTATIONS
32. Mizoribine in Living Donor Kidney Transplantation: Twenty four-week Results of A Single Center, Pre-randomized, Open-label, Prospective, Comparative, Phase III Study*
33. Communicating Risks to Potential Living Kidney Donors: A Systematic Review.
34. Different Recurrence Rates Between Pediatric and Adult Renal Transplantation for IgAN: Predictors of Posttransplantation Recurrence.
35. CLINICAL SIGNIFICANCE OF THE ELEVATED LIVER ENZYMES AFTER LIVING DONOR LIVER TRANSPLANTATION.
36. Long-Term Results of Biliary Atresia in the Era of Liver Transplantation.
37. Influence of Interleukin-17f Gene Polymorphisms on Renal Transplantation Outcome.
38. The Protective Effect of Ischemic Preconditioning Against Hepatic Ischemic/Reperfusion Injury Under Isoflurane Anesthesia in Rats.
39. Functional Characteristics of C-Terminal Lysine to Cysteine Mutant form of CTLA4Ig.
40. Mizoribine Versus Mycophenolatemofetil in Combination Therapy with Tacrolimus for De Novo Kidney Transplantation: Efficacy and Safety Evaluation.
41. Comparison Between Horse and Rabbit Antithymocyte Globulin as an Induction Agent in Kidney Transplantation: A Single Center Experience.
42. Clinical Implication of Latant Mesangial IgA Deposition in Renal Allograft Donors in Korea.
43. Preemptive Antiviral Agents in Kidney Transplant Recipients with Hepatitis B Virus Infection Reduced the Risk of Hepatitis B Virus Reactivation.
44. Clinical Significance of Proteinuria at Posttransplant 1 Year in Kidney Transplantation.
45. Porcine Islet Adaptation to Metabolic Need of the Monkeys in Pig to Monkey Intraportal Islet Xenotransplantation.
46. Comparative Characteristics of Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients.
47. Islet Isolation from the Rhesus Macaques Using a GMP-Grade Enzyme.
48. Soluble Human TNFRI-Fc and HO-1 Gene Transfection Into Porcine Islet Can Prolong Islet Graft Survival.
49. Different Etiologies and Prognostic Factors after Liver Transplantation for Fulminant Hepatic Failure in Korea.
50. How Can We Expand the Criteria of Liver Transplantation in Hepatocellular Carcinoma?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.